ZA929622B - Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level - Google Patents

Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level

Info

Publication number
ZA929622B
ZA929622B ZA929622A ZA929622A ZA929622B ZA 929622 B ZA929622 B ZA 929622B ZA 929622 A ZA929622 A ZA 929622A ZA 929622 A ZA929622 A ZA 929622A ZA 929622 B ZA929622 B ZA 929622B
Authority
ZA
South Africa
Prior art keywords
preparation
pharmaceutical composition
blood lipid
lipid level
composition selectively
Prior art date
Application number
ZA929622A
Other languages
English (en)
Inventor
Mate Hidvegi
Original Assignee
Mate Hidvegi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mate Hidvegi filed Critical Mate Hidvegi
Publication of ZA929622B publication Critical patent/ZA929622B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA929622A 1991-12-12 1992-12-11 Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level ZA929622B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU913928A HU208256B (en) 1991-12-12 1991-12-12 Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood

Publications (1)

Publication Number Publication Date
ZA929622B true ZA929622B (en) 1995-09-26

Family

ID=10966105

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA929622A ZA929622B (en) 1991-12-12 1992-12-11 Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level

Country Status (25)

Country Link
US (1) US5277910A (fi)
JP (1) JPH05286865A (fi)
KR (1) KR930012033A (fi)
CN (1) CN1074123A (fi)
AT (1) ATA243992A (fi)
AU (1) AU657822B2 (fi)
BE (1) BE1006341A3 (fi)
CA (1) CA2085215A1 (fi)
CZ (1) CZ363492A3 (fi)
DE (1) DE4242149A1 (fi)
DK (1) DK148092A (fi)
ES (1) ES2055659B1 (fi)
FI (1) FI925633A (fi)
FR (1) FR2684877B1 (fi)
GB (1) GB2262230B (fi)
GR (1) GR920100548A (fi)
HU (1) HU208256B (fi)
IL (1) IL104067A0 (fi)
IT (1) IT1256652B (fi)
LU (1) LU88200A1 (fi)
MX (1) MX9207222A (fi)
NL (1) NL9202144A (fi)
PL (1) PL296972A1 (fi)
SE (1) SE9203744L (fi)
ZA (1) ZA929622B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208256B (en) * 1991-12-12 1993-09-28 Mate Hidvegi Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood
AU7250694A (en) * 1993-06-25 1995-01-17 Biosphere Technologies Inc. Dietary supplement incorporating beta-sitosterol and pectin
US5674496A (en) * 1993-10-20 1997-10-07 New Mexico Tech Research Foundation Animal repellent
US6814962B1 (en) * 1994-06-02 2004-11-09 Aventis Pharma S.A. Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
US5516528A (en) * 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US6193766B1 (en) * 1996-06-27 2001-02-27 Barto/Jordan Company, Inc. Alfalfa extract fuel additive for reducing pollutant emissions
US6086882A (en) * 1997-08-06 2000-07-11 National Institute For Pharmaceutical Research Phytodrug for management of peptic ulcer and methods of preparing and using same
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
GB2327607B8 (en) * 1997-07-31 2005-03-30 Litton Internat Company Ltd A process for producing a herbal extract composition
DE19750453A1 (de) * 1997-11-14 1999-05-27 Henkel Kgaa Verwendung von Wirkstoffmischungen zur Herstellung von hypocholesterinämischen Mitteln
US6232351B1 (en) 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
US6150399A (en) * 1998-06-30 2000-11-21 Abbott Laboratories Soy-based nutritional products
DE19857816C2 (de) 1998-12-15 2001-02-01 Bionorica Arzneimittel Gmbh Fließfähige, pressfertige Arzneimittelvorprodukte für Tabletten, Pellets und Dragees, sowie Verfahren zu deren Herstellung
FR2794616B1 (fr) * 1999-06-11 2001-09-07 Tekory S A R L Supplement alimentaire naturel destine a diminuer le taux de cholesterol plasmatique et procede pour le preparer
US6503543B1 (en) * 2000-05-26 2003-01-07 Craig J. Hudson Tryptophan source from plants and uses therefor
US6866874B2 (en) 2000-05-26 2005-03-15 Susan P. Hudson Tryptophan source from plants and uses therefor
WO2002047612A2 (en) * 2000-10-27 2002-06-20 Mannatech, Inc. Dietary supplement compositions
US7815946B1 (en) * 2001-04-05 2010-10-19 Diakron Pharmaceuticals, Inc. Anti-diabetic and cholesterol lowering preparation from fenugreek seeds
JP5110673B2 (ja) * 2001-07-10 2012-12-26 丸善製薬株式会社 リパーゼ阻害剤
FR2854769B1 (fr) * 2003-05-16 2009-07-17 Alfalis Utilisation d'un extrait soluble de luzerne pour freiner la prise de poids chez les mammiferes
US20090318377A1 (en) * 2006-07-13 2009-12-24 Medicago Inc. Medicagenic acid saponin and uses thereof
US20090226549A1 (en) * 2008-03-06 2009-09-10 Kenneth John Hughes Herbal extracts and flavor systems for oral products and methods of making the same
CN103002871A (zh) * 2010-07-06 2013-03-27 荷兰联合利华有限公司 锦葵色素用来促进头发生长
KR20200040583A (ko) 2018-10-10 2020-04-20 (주)아모레퍼시픽 코티존 환원효소 저해용 조성물
CN114853918B (zh) * 2022-04-26 2023-03-31 沈阳化工大学 一种具有抗氧化降脂活性的紫花苜蓿根部多糖制备方法
CN115490584B (zh) * 2022-09-28 2023-07-14 厦门中药厂有限公司 Megastigmane类化合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1136626A (en) * 1965-10-22 1968-12-11 Nat Res Dev Improvements relating to the extraction of saponins and sapogenins from vegetable materials
US3780183A (en) * 1971-01-25 1973-12-18 Edwards G Wheeler Plant protein product and process
US3901875A (en) * 1972-03-31 1975-08-26 Pacific Chem Ind Co Extraction of ginseng saponin
GB1378278A (en) * 1972-03-31 1974-12-27 Pacific Chem Ind Co Total saponin extracts from panax ginseng c a meyer and process for the production thereof
FR2187328A1 (en) * 1972-06-13 1974-01-18 Froment Pier E De Non-saponified lucerne extract - useful in dermatology cosmetology and as aid to cicatrisation
SU624634A1 (ru) * 1975-09-25 1978-09-25 Харьковский Научно-Исследовательский Химико-Фармацевтический Институт Способ получени ингибитора,обладающего антифибринолитическим и противовоспалительным действием
JPS59166055A (ja) * 1983-03-11 1984-09-19 Osaka Chem Lab 牧草を原料とする食品
JPS59175496A (ja) * 1983-03-23 1984-10-04 Osaka Chem Lab ソ−ヤサポニンの単離法
JPS646987A (en) * 1987-06-30 1989-01-11 Ricoh Kk Controlling method for toner concentration of developer for electrophotographic device
FR2669225B1 (fr) * 1990-11-21 1993-11-12 Lvmh Recherche Gie Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques.
HU208256B (en) * 1991-12-12 1993-09-28 Mate Hidvegi Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood

Also Published As

Publication number Publication date
FR2684877B1 (fr) 1994-12-30
DK148092A (da) 1993-06-13
PL296972A1 (en) 1993-08-23
LU88200A1 (fr) 1993-04-15
BE1006341A3 (fr) 1994-07-26
CZ363492A3 (en) 1993-09-15
IL104067A0 (en) 1993-05-13
GB2262230B (en) 1995-10-11
KR930012033A (ko) 1993-07-20
AU657822B2 (en) 1995-03-23
FR2684877A1 (fr) 1993-06-18
FI925633A0 (fi) 1992-12-11
NL9202144A (nl) 1993-07-01
DE4242149A1 (fi) 1993-06-17
ES2055659A1 (es) 1994-08-16
DK148092D0 (da) 1992-12-09
GR920100548A (el) 1993-08-31
HU913928D0 (en) 1992-02-28
AU3005492A (en) 1993-06-17
JPH05286865A (ja) 1993-11-02
GB9225866D0 (en) 1993-02-03
IT1256652B (it) 1995-12-12
CA2085215A1 (en) 1993-06-13
CN1074123A (zh) 1993-07-14
GB2262230A (en) 1993-06-16
SE9203744L (sv) 1993-06-13
FI925633A (fi) 1993-06-13
MX9207222A (es) 1993-06-01
HU208256B (en) 1993-09-28
ITMI922842A0 (it) 1992-12-11
ES2055659B1 (es) 1995-03-01
ITMI922842A1 (it) 1994-06-11
SE9203744D0 (sv) 1992-12-11
US5277910A (en) 1994-01-11
ATA243992A (de) 2000-02-15

Similar Documents

Publication Publication Date Title
ZA929622B (en) Process for the preparation of a pharmaceutical composition selectively lowering the blood lipid level
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
EG18603A (en) A method for the preparation of pharmaceutical composition
EP0548537A3 (en) Apparatus for the preparation of a medical liquid
HU895444D0 (en) Process for the preparation of ophthalmic pharmaceutical composition
ZA895838B (en) Pharmaceutical compounds
GB2228412B (en) Nicardipine pharmaceutical composition for parenteral administration
ZA89260B (en) Pharmaceutical compounds
IL87921A0 (en) Pharmaceutical composition for piperidinoalkanol derivatives
ZA90341B (en) Liquid pharmaceutical composition for piperidinoalkanol derivatives
GB8916682D0 (en) Pharmaceutical compounds
IL102895A0 (en) Pharmaceutical compositions for lowering blood lipid levels
EG18306A (en) A process for the preparation of pharmaceutical compounds
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
ZA89552B (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
IL95105A0 (en) Oral pharmaceutical compositions having controlled bioavailability
IL103922A0 (en) Process for the preparation of trifluorobenzene derivatives
PT86527A (en) Process for the preparation of 4-arylcarbonyl-1-](4-morpholinyl)-lower-alkyl"-1h-indoles
IL87818A0 (en) Pharmaceutical compositions containing 7-diphenylmethylenebicycloheptane or 7-diphenylmethylenecycloheptene derivatives and new 7-diphenylmethylenebicycloheptanes and 7-diphenylmethylenebicycloheptenes and processes for the preparation thereof
EP0373919A3 (en) Process for the preparation of 2'-deoxy-beta-adenosine
HU896023D0 (en) Process for the preparation of pharmaceutical composition
GB8803776D0 (en) Novel pharmaceutical compounds & their preparation
ZA887411B (en) Pharmaceutical composition for piperidinoalkanol derivatives
IE872126L (en) Pharmaceutical compounds
HU913995D0 (en) Process for the production of medical preparation